Healthcare Triangle Inc SEC Filings

Healthcare Triangle (HCTI) called its 2025 Annual Meeting for November 7, 2025 at 10:00 a.m. Pacific Time, to be held virtually. Stockholders will vote to elect four directors and to ratify SRCO Professional Corporation as the independent registered public accounting firm for the fiscal year ending December 31, 2025. The Board unanimously recommends voting FOR all nominees and FOR auditor ratification.

Only stockholders of record at the close of business on September 29, 2025 may vote. Registration to attend is required by November 5, 2025 at 11:59 p.m. Eastern Time. Nominees are Dave Rosa, Sujatha Ramesh, Ronald McClurg, and Jainal Bhuiyan.

SRCO has served as auditor since April 2025; prior reports by M&K CPAS, PLLC contained no adverse opinions or modifications. As context, Suresh Venkatachari holds Series A Super Voting Preferred Shares representing 77.11% of voting power as of October 15, 2025. Shares outstanding were 5,873,304 common and 20,000 Series A Super Voting Preferred as of October 15, 2025.

Healthcare Triangle, Inc. (HCTI) reported that a holder of approximately 81.82% of its voting power approved, by written consent, the issuance of 1,388,041 restricted common shares to Niyama Healthcare, Inc. as partial consideration for an acquisition. The deal also includes $1.5 million in cash (with $1.2 million paid at closing and $300,000 payable later) and up to $1.2 million in earn-out payments tied to first‑year performance targets to be agreed within 90 days of closing.

The shares are being issued under Nasdaq Listing Rule 5635(a)(2). The action becomes effective 20 calendar days after mailing of the information statement. Shares outstanding were 5,831,829 as of September 19, 2025; this is a baseline figure, not the amount being issued.

HCTI acquired the seller’s cloud and technology domain assets and 100% of Ezovion Solutions Private Limited, a hospital information systems SaaS provider in Chennai, India. No proxy is being solicited, and no further shareholder action is required.

Healthcare Triangle, Inc. is circulating a preliminary proxy statement for a virtual annual meeting that includes three explicit actions: elect four directors to serve until the 2026 annual meeting, ratify the appointment of SRCO Professional Corporation, Chartered Professional Accountants as the independent registered public accounting firm for the fiscal year ending December 31, 2025, and transact any other properly presented business. The materials describe voting mechanics for record holders and beneficial holders, note that a quorum requires a majority of outstanding voting stock, and state there are 20,000 shares of Series A Super Voting Preferred Stock outstanding with 1,000 votes per share; the number of common shares outstanding is presented as a placeholder and not specified. The company will pay proxy-solicitation costs and reimburse brokers for forwarding materials. Healthcare Triangle discloses it is an "emerging growth company" and summarizes committee responsibilities, director names and ages (Dave Rosa, Sujatha Ramesh, Ronald McClurg, Jainal Bhuiyan). Several ownership and disclosure fields in the filing appear as placeholders or truncated.

L1 Capital Global Opportunities Master Fund, Ltd. filed an amendment to Schedule 13G reporting beneficial ownership of 1,417,420 shares of Healthcare Triangle, Inc. (HCTI), equal to 0.35% of the company's outstanding common stock based on 408,445,597 shares. The filing states this total includes 464,681 shares issued on conversion of $200,000 of a convertible promissory note, 595,239 shares underlying warrants and 357,500 shares underlying additional warrants. The report notes it does not reflect potential additional securities from anti-dilution protection and that beneficial ownership would be limited to 9.9% even if related discussions were resolved within 60 days. Directors David Feldman and Joel Arber are identified in the filing.

Healthcare Triangle, Inc. (HCTI) reported a quarter showing a completed acquisition, a large reverse stock split and continued operating losses. On June 16, 2025 the company closed an asset acquisition for $5.7 million comprised of $1.5 million cash (with $1.2 million paid at closing and $300,000 payable later), restricted common stock equal to $3.0 million issued at roughly $2.16–$2.17 per share, and up to $1.2 million of contingent earn-outs. The Company effected a 1-for-249 reverse split of common stock on August 1, 2025 and adjusted basic and diluted earnings for all periods. Cash and cash equivalents changed by +$3,208 (net increase) for the period reported. The company reported net losses reflected in negative basic and diluted EPS (examples shown: $(0.58) and $(70.72) in one presentation and $(2.56) and $(171.85) in another), high customer concentration in receivables (five customers represented ~52% and ~72% of accounts receivable), and a financing that produced net proceeds of approximately $13,676 after fees.